Markets
MRK

Sector Update: Healthcare

A generic image of a stock chart.
Credit: Shutterstock photo

Healthcare shares were flat to higher in pre-market trade on Tuesday.

In healthcare stocks news, Merck ( MRK ) was up 1% after it announced Q1 2014 results of $0.88 EPS, up from $0.85 in Q1 2013 and beating analyst estimates of $0.79. Worldwide sales were $10.26 billion for Q1, a decrease of 4% compared with $10.67 billion the Q1 2013 and missing analyst projections of $10.44 billion.

The company has confirmed its 2014 full-year non-GAAP EPS target of $3.35 to $3.53 and continues to expect full-year 2014 revenues to be between $42.4 billion and $43.2 billion.

And, Alere ( ALR ) announced plans to pursue an initial public offering in the United Kingdom of the ordinary shares of BBI Diagnostics Group plc, or BBI Diagnostics, a new subsidiary formed for purposes of the offering. reported Q1 earnings that met the Street view.

Alere also reported non-GAAP adjusted net income per diluted common share of $0.55 for Q1 2014 and net revenue of $716.6 million for Q1 2014. The Street expected earnings of $0.55 per share on revenue of $739 million, according to Capital IQ estimates.

Finally, CryoLife ( CRY ) reported Q1 earnings of $0.04 per share and revenue of $35.7 million, both of which missed the Street view.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MRK CRY

Other Topics

Commodities